| Literature DB >> 27266275 |
Qingbo Li1, Chuanying Wang2, Yanqing Huo1, Zhiwei Jia3, Xiqian Wang1.
Abstract
BACKGROUND: A number of meta-analyses have been carried out to evaluate the effects of minimally invasive surgery (MIS) versus open surgery (OS) for acute Achilles tendon rupture. However, discordant findings were seen in these meta-analyses. The present study, performing a systematic review of overlapping meta-analyses regarding MIS versus OS of acute Achilles tendon rupture, aimed to assist decision-makers interpret and choose among conflicting meta-analyses, as well as to offer treatment recommendations based on current best evidence.Entities:
Keywords: Achilles tendon rupture; Meta-analysis; Minimally invasive surgery; Open surgery; Systematic review
Mesh:
Year: 2016 PMID: 27266275 PMCID: PMC4893828 DOI: 10.1186/s13018-016-0401-2
Source DB: PubMed Journal: J Orthop Surg Res ISSN: 1749-799X Impact factor: 2.359
Fig. 1The flow chart of study selection
The characteristics of the included studies
| First author | Year | Journal | Date of last literature search | No. of included RCTs |
|---|---|---|---|---|
| Khan RJ | 2005 | The Journal of Bone and Joint Surgery, American Volume | NA | 2 |
| Khan RJ | 2010 | Cochrane Database of Systematic Reviews | July 2009 | 4 |
| McMahon SE | 2011 | Foot and Ankle Surgery | March 2010 | 6 |
| Jones MP | 2012 | The Journal of Bone and Joint Surgery American Volume | NA | 4 |
RCTs randomized clinical trials, NA not available
Primary studies included in meta-analyses
| First author (Year) | Schroeder D (1997) | Majewski M (2000) | Lim J (2001) | Gigante A (2008) | Aktas S (2009) | Valencia AJA (2009) |
|---|---|---|---|---|---|---|
| Khan RJ (2005) | + | + | ||||
| Khan RJ (2010) | + | + | + | + | ||
| McMahon SE (2011) | + | + | + | + | + | + |
| Jones MP (2012) | + | + | + | + |
Search methodology of the included studies
| First author (year) | Restriction of publication language | Restriction of publication status | Search database | |||||
|---|---|---|---|---|---|---|---|---|
| PubMed | MEDLINE | Embase | Cochrane Library | CINAHL | Others | |||
| Khan RJ (2005) | No | No | + | + | + | + | + | |
| Khan RJ (2010) | No | No | + | + | + | + | + | |
| McMahon SE (2011) | No | No | + | + | + | + | + | |
| Jones MP (2012) | No | No | + | + | + | + | + | |
Methodological information of the included studies
| First author (year) | Design of included studies | Level of evidence | Software | GRADE use | Sensitivity analysis |
|---|---|---|---|---|---|
| Khan RJ (2005) | RCT or quasi-RCT | Level II | NA | No | No |
| Khan RJ (2010) | RCT or quasi-RCT | Level II | NA | No | No |
| McMahon SE (2011) | RCT or quasi-RCT | Level II | RevMan | No | No |
| Jones MP (2012) | RCT or quasi-RCT | Level II | NA | No | No |
RCT randomized controlled trial, NA not available
AMSTAR scores of the included studies
| Items | Khan RJ (2005) | Khan RJ (2010) | McMahon SE (2011) | Jones MP (2012) |
|---|---|---|---|---|
| 1. Was an a priori design provided? | 0 | 1 | 0 | 1 |
| 2. Was there duplicate study selection and data extraction? | 1 | 1 | 1 | 1 |
| 3. Was a comprehensive literature search performed? | 1 | 1 | 1 | 1 |
| 4. Was the status of publication (i.e., grey literature) used as an inclusion criterion? | 0 | 1 | 1 | 1 |
| 5. Was a list of studies (included and excluded) provided? | 1 | 1 | 0 | 1 |
| 6. Were the characteristics of the included studies provided? | 0 | 1 | 1 | 1 |
| 7. Was the scientific quality of the included studies assessed and documented? | 1 | 1 | 1 | 1 |
| 8. Was the scientific quality of the included studies used appropriately in formulating conclusions? | 1 | 1 | 1 | 1 |
| 9. Were the methods used to combine the findings of studies appropriate? | 1 | 1 | 1 | 1 |
| 10. Was the likelihood of publication bias assessed? | 0 | 0 | 1 | 0 |
| 11. Was the conflict of interest stated? | 1 | 1 | 1 | 1 |
| Total scores | 7 | 10 | 9 | 10 |
I 2 statistic value of each variable in each meta-analysis
| Items | Khan RJ (2005) | Khan RJ (2010) | McMahon SE (2011) | Jones MP (2012) |
|---|---|---|---|---|
| Rerupture | NA | 0.0 % | 0 % | NA |
| Complications excluding rerupture | 0.0 % | |||
| Superficial infection | 0.0 % | 0 % | ||
| Deep infection | 0.0 % | 0 % | ||
| Wound infection | 0.0 % | 0.0 % | 0 % | |
| Deep vein thrombosis | 0.0 % | 0 % | ||
| Delayed wound healing | NA | |||
| Ankle stiffness | NA | |||
| Disturbing scar/wound puckering | 64 % | |||
| Adhesions | 0.0 % | 0 % | ||
| Failed repair (tendon elongation) | NA | |||
| Hematoma | NA | |||
| Keloid formation | NA | |||
| Sural nerve injury | NA | 0 % | ||
| Tendinopathy | NA | |||
| SF-12 physical component | NA | |||
| Subjective outcomes (good to excellent) | 0 % | |||
| Subjective outcomes (fair) | 76 % |
NA not available
Fig. 2Results of the included meta-analyses
Fig. 3The flow chart of the Jadad decision algorithm